Universal solid tumor therapy with CD5-deleted, DSG2-directed CAR-T cells.

Authors

Publication/Presentation Date

5-2025

Volume

43

Issue

16

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article

Share

COinS